Galderma Group AG banner

Wall St Price Targets

GDERF Price Forecast
Based on 20 analysts

+14% Upside
from $226 today

Galderma Group AG (GDERF)’s 12-month stock price forecast through October 2027 has a consensus target of $258.67, implying 14% upside. The forecast is based on price targets from 20 Wall Street analysts.

GDERF Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for GDERF yet.

Galderma Group AG Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GDERF's stock price target?
Price Target
258.67 USD

According to Wall Street analysts, the average 1-year price target for GDERF is 258.67 USD with a low forecast of 193.06 USD and a high forecast of 346.17 USD.

What is the Revenue forecast for Galderma Group AG?
Projected CAGR
13%

Over the last 3 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 13%.

What is the Gross Profit forecast for Galderma Group AG?
Projected CAGR
15%

Over the last 3 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 8 years is 15%.

What is the Operating Income forecast for Galderma Group AG?
Projected CAGR
20%

Over the last 3 years, the compound annual growth rate for Operating Income has been 30%. The projected CAGR for the next 8 years is 20%.

What is the Pre-Tax Income forecast for Galderma Group AG?
Projected CAGR
58%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 58%.

What is the Net Income forecast for Galderma Group AG?
Projected CAGR
28%

The compound annual growth rate for Net Income over the next 8 years is 28%.

Back to Top